Clinical Trial Update: Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether LoDoCo improves exercise capacity in patients with heart failure with preserved ejection fraction and inflammation. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Inflammation

Drugs mentioned

• LoDoCo (colchicine)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Heart Failure, Inflammation | Phase 2 | Status: RECRUITING